By conducting Cox univariate analysis on clinical-pathology-immune factors (Supplemental Table 2), we identified the presence of MVI, incomplete tumor capsule, and low CD4+ T cell infiltration in the CT region as risk factors which decreased RFS (Figure 3A). This evidence concerns the gene CD4 and neoplasm.